Credit Suisse’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-27,449
| Closed | -$130K | – | 3667 |
|
|
2021
Q1 | $130K | Sell |
27,449
-6,194
| -18% | -$29.3K | ﹤0.01% | 3316 |
|
|
2020
Q4 | $240K | Buy |
33,643
+9,609
| +40% | +$68.5K | ﹤0.01% | 3197 |
|
|
2020
Q3 | $257K | Sell |
24,034
-35,912
| -60% | -$384K | ﹤0.01% | 2993 |
|
|
2020
Q2 | $756K | Buy |
59,946
+33,029
| +123% | +$417K | ﹤0.01% | 2472 |
|
|
2020
Q1 | $247K | Sell |
26,917
-6,111
| -19% | -$56.1K | ﹤0.01% | 2938 |
|
|
2019
Q4 | $461K | Buy |
33,028
+12,713
| +63% | +$177K | ﹤0.01% | 2961 |
|
|
2019
Q3 | $350K | Buy |
20,315
+2,354
| +13% | +$40.6K | ﹤0.01% | 2971 |
|
|
2019
Q2 | $488K | Buy |
17,961
+4,685
| +35% | +$127K | ﹤0.01% | 2804 |
|
|
2019
Q1 | $255K | Buy |
13,276
+274
| +2% | +$5.26K | ﹤0.01% | 3087 |
|
|
2018
Q4 | $121K | Buy |
+13,002
| New | +$121K | ﹤0.01% | 3208 |
|
|
2018
Q3 | – | Sell |
-13,474
| Closed | -$264K | – | 3434 |
|
|
2018
Q2 | $264K | Sell |
13,474
-232
| -2% | -$4.55K | ﹤0.01% | 3212 |
|
|
2018
Q1 | $257K | Buy |
+13,706
| New | +$257K | ﹤0.01% | 3203 |
|
|
2017
Q4 | – | Sell |
-10,969
| Closed | -$226K | – | 3632 |
|
|
2017
Q3 | $226K | Buy |
+10,969
| New | +$226K | ﹤0.01% | 3393 |
|